J&J to open med-tech incubator in Israel with Orbimed, Takeda
Jan. 12, 2014
One way pharma giant Johnson and Johnson stays ahead of the competition is via its network of Innovation Centers where researchers are working on new approaches to cardiovascular issues, infectious diseases, neuroscience, and more.
The centers are located in San Francisco, Boston, London, and Shanghai – and this week the company announced that Israel was joining the family, in the form of an incubator J&J will be opening in Rehovot, near the Weizmann Institute. Working together with several other partners, the company said, the new incubator “is the latest in a series of recently announced collaborations to fuel entrepreneurship in the world’s scientific hot spots.”
The center is the result of collaboration by J&J with the Chief Scientists Office, Japan’s Takeda Pharmaceuticals, and Israeli company OrbiMed, the Rehovot center, Johnson and Johnson said, will work on some of the company’s most advanced projects, the company added. The incubator, one of several to be opened in the coming months, will become operational over the next month or two.
The Chief Scientist’s office awarded the companies the tender for establishing the incubator last August. The government will kick in about $2 million over the next 3 years for the project; J&J and its partners have pledged more than $28 million to fund it as well.
For the full news story on Israel21c click here.